PPARA and diabetes mellitus: Fenofibrate, a PPAR-α (peroxisome proliferator-activated receptor alpha) agonist, is usually prescribed for lowering mainly triglycerides and was demonstrated to reduce the progression of DR and the need for laser treatment in the FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study [7].